IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1872 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded275    
    Comments [Add]    

Recommend this journal


Year : 1998  |  Volume : 30  |  Issue : 4  |  Page : 209-217

Treatment of arsenic poisoning: An update

Correspondence Address:
SJS Flora

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Arsenic, a metalloid of highly toxic nature is present throughout the earth's crust. In India about 40 lakhs of people in West Bengal suffer from arsenic poisoning due to drinking water contamination. British Anti lewisite (BAL) is used for the treatment of arsenic poisoning. However, the chelator has low safety ratio and unpleasant side effects. Recently, few analogues of BAL, viz., meso 2,3-dimercaptosuccinic acid (DMSA) and sodium 2,3-dimercaptopropane 1 sulfonate (DMPS) beside few diesters and monoesters of DMSA have been successfully tried both in humans as well as in experimental models of acute and chronic arsenic poisoning. This article presents in briefly the recent development made in this area with possible directions for future research.


Print this article     Email this article

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow